Combined Therapy with Dobutamine and Amrinone in Severe Heart Failure
- 1 October 1987
- Vol. 92 (4) , 657-662
- https://doi.org/10.1378/chest.92.4.657
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failureThe American Journal of Cardiology, 1986
- MDL 17,043 therapy in severe congestive heart failure: Characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical responseJournal of the American College of Cardiology, 1985
- The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.Circulation, 1983
- Isoproterenol-stimulated renin secretion in the rat: Second messenger roles of Ca and cyclic AMPLife Sciences, 1982
- Amrinone and exercise performance in patients with chronic heart failureThe American Journal of Cardiology, 1981
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978
- Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.Circulation, 1978
- Comparative responses to dobutamine and nitroprusside in patients with chronic low output cardiac failure.Circulation, 1977
- The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.Circulation, 1977
- Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.Circulation, 1977